A sonicated dispersion of the lipid A analog, E5531 was freeze-dried in the presence of various additives such as saccharides and polyalchols and their cryoprotective effects were investigated. Fusion of the vesicles was measured by determining fluorescence energy transfer and size distribution. The ability of the additives as cryoprotectants was varied. The addition of polyalcohols led to considerable fusion. Although monosaccharides, similar to disaccharides, completely prevented the fusion of the vesicles during lyophilization, they showed far less ability to retain the entrapped calcein of the vesicles compared to disaccharides. Differential scanning calorimetry heating profiles of vesicles that had been lyophilized with various additives were obtained. Disaccharides and monosaccharides again markedly differed in the thermal properties. This variety in cryoprotective ability can be attributed to differences in the extent of their interaction with the E5531 head group.
Introduction
Lipid A is a component of bacterial lipopolysaccharide(LPS), and is present in the major amphiphilic constituents of the leaflets of Gram-negative bacteria. It is a potent biological active site1,2) and induces the production of prostagrandins, cytokines such as interferon3), interleukin 14) and tumor necrosis factor (TNF) in mammalian cells, such as macropharges and lymphocytes. This compound also induces undesirable toxic effects such as fever and the Schwartzmann bleeding reaction. 5) Numerous attempts have been made to synthesize low toxicity lipid A analogs. Recent work in our laboratories indicates that some lipid A analogs may be potent LPS antagonists.6) While the synthetic disaccharide lipid A analog E5531 (Fig. 1) has a low toxicity, it retains a variety of useful biological activities such as its ability to inhibit the production of TNF.6) This compound has been found to be a specific LPS antagonist, as evidenced by an LPS binding assay, and inhibits LPS induced TNF production in monocytes/ macropharges. The anticipated use for the compound is as a drug for the treatment of septic shock and, because of this, an injectable formulation would be extremely useful.
Because E5531 is not stable at the conditions used for sterile sterilization, a dispersion of E5531 can be freeze-dried for parental use. As is the case of liposomes prepared from phospholipids7,8), the stabilizers such as saccharides are added to the dispersion.
However, in case of the lipid A analogs, our understanding of the freeze-drying and stabilization mechanisms is limited.
We report here on an investigation of the difference in the cryoprotective ability of various additives such as saccharides and polyalchols during the freeze-drying process. The effects of these compounds on the ther- 
Determination of trapped volume
The trapped volume inside the particles was determined in order to obtain information on the structure of the E5531 particles. Five milligrams of E5531 was dispersed in 2.5 ml of a 70 mM calcein solution (pH 7. This can be attributed to the formation of a eutetic mixture in the frozen state!) The fusion observed in these systems is probably caused by mechanical breakage during ice crystal formation and these compounds!)
The effect of various additives on the thermal properties of E5531 particles was investigated. The phase transition temperatures in DSC heating thermograms for each system are shown in Fig. 2 . The profile from third scan (Fig.2d) is almost the same as the second.
These results indicate that for a maximal effect, it is necessary for the lactose to interact with E5531 when it is in the liquid-crystalline phase.
In Fig. 3a, b 
